| Accounts Payable and Accrued Liabilities Disclosure [Text Block] |
|
7.
|
Accounts payable and Accrued Liabilities
|
| |
|
Accounts Payable
|
|
|
|
Accrued Liabilities
|
|
| |
|
March 31, 2025
|
|
|
December 31, 2024
|
|
|
|
March 31, 2025
|
|
|
December 31, 2024
|
|
|
Current accounts payable
|
|
$ |
530,751 |
|
|
$ |
524,355 |
|
Accrued liabilities
|
|
$ |
250,260 |
|
|
$ |
322,548 |
|
|
Deferred accounts payable
|
|
|
1,090,041 |
|
|
|
999,883 |
|
Deferred Compensation
to Directors (a)
|
|
|
1,806,433 |
|
|
|
1,723,048 |
|
|
Total
|
|
$ |
1,620,792 |
|
|
$ |
1,524,238 |
|
Total
|
|
$ |
2,056,693 |
|
|
$ |
2,045,596 |
|
| |
(a)
|
The director fees and interest accrued under the deferred Compensation Plan where most directors elected to defer 100% of their fees for 2025, 2024, 2023, 2022, 2021 and 2020 excluding Jan Loeb who was nominated to the Board on July 28, 2023, and elected to a three-year term at the annual shareholder meeting on October 12, 2023. This amount also includes the deferred compensation of a former Board advisor per an agreement to defer payments due under an advisor agreement and two previous Board members.
|
|